We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$6.24M
Cap. Flow
-$8.36M
Cap. Flow %
-0.43%
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 30.67%
2 Industrials 16.05%
3 Consumer Discretionary 13.81%
4 Technology 13.49%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFWM
251
DELISTED
First Foundation Inc
FFWM
-22,193
Closed -$455K
HUBS icon
252
HubSpot
HUBS
$11.8B
-2,741
Closed -$824K
LSCC icon
253
Lattice Semiconductor
LSCC
$17.2B
-208,107
Closed -$10.1M
ONTO icon
254
Onto Innovation
ONTO
$13.9B
-286,688
Closed -$20M
PLTR icon
255
Palantir
PLTR
$323B
-12,721
Closed -$115K
RNG icon
256
RingCentral
RNG
$3.42B
-1,587
Closed -$83K
SMTC icon
257
Semtech
SMTC
$11.7B
-220,705
Closed -$12.1M
SWIM icon
258
Latham Group
SWIM
$717M
-11,860
Closed -$82K
TIGO icon
259
Millicom
TIGO
$16.3B
$0 ﹤0.01%
22
TLYS icon
260
Tilly's
TLYS
$118M
-470,436
Closed -$3.3M
PING
261
DELISTED
Ping Identity Holding Corp.
PING
-783,181
Closed -$14.2M
SAIL
262
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
-2,107
Closed -$132K
QTWW
263
DELISTED
QUANTUM FUEL SYS TECHNOLOGIES WORLDWIDE INC COM STK (DE)
QTWW
$0 ﹤0.01%
15
BHVN
264
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-171,023
Closed -$24.9M

Similar funds

Emerald Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Advisers held 264 positions worth $1.94B, down 0.32% from $1.94B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2022 filing shows 14 new, 88 increased, 101 reduced and 15 closed positions. Its largest new stake was Blueprint Medicines: 318,574 shares worth $21M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2022 buy was Blueprint Medicines: 318,574 shares worth $21M.
  • Emerald Advisers added most to AdaptHealth in Q3 2022, an estimated $19.3M increase.
  • Emerald Advisers's biggest Q3 2022 reduction was Avient, cutting an estimated $21.7M.
  • Emerald Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $24.9M.
  • Emerald Advisers's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2022.
  • Emerald Advisers opened 14 new positions and closed 15 in Q3 2022.
  • Emerald Advisers's portfolio value fell 0.32% quarter-over-quarter to $1.94B.

Based on Emerald Advisers's 13F filing for Q3 2022, filed 25 Oct 2022.